全身弥散加权成像在多种恶性肿瘤转移筛查中的准确性:与传统横断面影像及核素显像的比较
本研究评估全身弥散加权成像(WB DWI)作为转移灶筛查手段的作用,并与传统横断面影像或核素显像在多种组织病理学恶性肿瘤患者中比较。WB DWI在检测肝转移和骨转移方面略逊于传统影像但差异无统计学意义(肝转移p=0.625,骨转移p=0.0953,McNemar检验),在淋巴结转移(p=0.0389)和肺转移(p=0.045)检测方面显著劣于传统影像。结论认为WB DWI可用于肝转移和骨转移筛查,但作为检测淋巴结和肺转移的唯一成像序列可靠性差,目前不能替代传统影像。
要点
- WB DWI检测肝转移和骨转移的敏感度、特异度及准确率略低于传统影像,但差异无统计学意义。
- WB DWI检测淋巴结转移的敏感度74.0%、特异度87.9%、准确率81.4%,显著低于传统影像(p=0.0389)。
- WB DWI检测肺转移的敏感度仅33.3%,显著低于传统影像的100.0%(p=0.045)。
核心结论
- WB DWI可用于肝转移和骨转移筛查,但作为检测淋巴结和肺转移的唯一成像序列可靠性差,目前不能替代传统影像。
研究设计与样本
- 研究纳入已知恶性肿瘤需转移灶检查的患者,行WB DWI及传统影像(CT、MRI或闪烁显像),随访1年;两名放射科医生独立评估WB DW图像,传统图像由资深放射科医生评估;以组织病理学确认或临床随访为参考标准。
诊断标准与关键数值
- 肝转移:WB DWI敏感度86.6%、特异度91.6%、准确率89.7%;传统影像敏感度93.3%、特异度95.8%、准确率94.8%;差异无统计学意义(p=0.625,McNemar检验)。
- 骨转移:WB DWI敏感度81.8%、特异度86.4%、准确率85.2%;传统影像敏感度89.4%、特异度94.3%、准确率93.0%;差异无统计学意义(p=0.0953,McNemar检验)。
- 淋巴结转移:WB DWI敏感度74.0%、特异度87.9%、准确率81.4%;传统影像敏感度81.5%、特异度90.1%、准确率86.0%;WB DWI显著劣于传统影像(p=0.0389)。
- 肺转移:WB DWI敏感度33.3%、特异度90.9%、准确率60.8%;传统影像敏感度100.0%、特异度100.0%、准确率100.0%;WB DWI显著劣于传统影像(p=0.045)。
临床应用与阅片要点
- WB DWI可用于肝转移和骨转移的筛查。
- WB DWI作为检测淋巴结转移和肺转移的唯一成像序列可靠性差,目前不能替代传统影像。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The purpose of this study is to assess the role of whole-body (WB) DWI as a screening modality for the detection of metastases and to compare it to conventional cross-sectional imaging modalities or nuclear scintigraphy in a population with various histopathologic malignancies.
SUBJECTS AND METHODS: WB DWI and conventional imaging (CT, MRI, or scintigraphy) were performed for patients with known malignancies for metastatic workup, and these patients were followed up for a period of 1 year. Two radiologists assessed WB DW images separately, and conventional images were assessed by the senior radiologist. The metastatic lesions were classified into four regions: liver, lung, skeletal system, and lymph nodes. The reference standard was considered on the basis of histopathologic confirmation or clinical follow-up of the metastatic lesions.
RESULTS: WB DWI was slightly inferior to conventional imaging modalities for the detection of hepatic metastases (sensitivity, 86.6% vs 93.3%; specificity, 91.6% vs 95.8%; and accuracy, 89.7% vs 94.8%) and skeletal metastases (sensitivity, 81.8% vs 89.4%; specificity, 86.4% vs 94.3%; and accuracy, 85.2% vs 93.0%); however, the differences were not statistically significant (p = 0.625 for hepatic metastases and p = 0.0953 for skeletal metastases, McNemar test). WB DWI was statistically significantly inferior to conventional imaging for the detection of lymph node metastases (sensitivity, 74.0% vs 81.5%; specificity, 87.9% vs 90.1%; accuracy, 81.4% vs 86.0%; p = 0.0389). WB DWI was statistically significantly inferior to conventional imaging for the detection of pulmonary metastases (sensitivity, 33.3% vs 100.0%; specificity, 90.9% vs 100.0%; accuracy, 60.8% vs 100.0%; p = 0.045).
CONCLUSION: WB DWI can be used for screening hepatic and skeletal metastases, but its reliability as the sole imaging sequence for the detection of lymph nodal and pulmonary metastases is poor and, at present, it cannot replace conventional imaging modalities.
引用
- Paruthikunnan SM, Kadavigere R, Karegowda LH, et al. Accuracy of Whole-Body DWI for Metastases Screening in a Diverse Group of Malignancies: Comparison With Conventional Cross-Sectional Imaging and Nuclear Scintigraphy. AJR Am J Roentgenol. 2017. PMID: 28678578. doi:10.2214/AJR.17.17829
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。